Characteristics | Samples | Percent (%) | |
---|---|---|---|
Gender | Female | 179 | 45.3 |
Male | 216 | 54.7 | |
Age |  ≤ 60y | 119 | 30.1 |
 > 60y | 276 | 69.9 | |
Clinical stages | Stage I | 67 | 17 |
Stage II | 153 | 38.7 | |
Stage III | 113 | 28.6 | |
Stage IV | 51 | 12.9 | |
Unknown | 11 | 2.8 | |
T stages | T0/Tis | 1 | 0.3 |
T1 | 9 | 2.3 | |
T2 | 68 | 17.2 | |
T3 | 269 | 68.1 | |
T4 | 48 | 12.2 | |
N stages | N0 | 233 | 59 |
N1 | 95 | 24 | |
N2 | 67 | 17 | |
M stages | M0 | 297 | 75.2 |
M1 | 51 | 12.9 | |
Unknown | 47 | 11.9 | |
Survival status | Alive | 323 | 81.8 |
Dead | 72 | 18.2 | |
Treatment or therapy | Yes | 67 | 17 |
No | 296 | 74.9 | |
Unknown | 32 | 8.1 |